Confirm Rx
Device
Abbott Laboratories
Total Payments
$3.7M
Transactions
29,400
Doctors
7,986
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $142,768 | 20 | 0 |
| 2023 | $789,460 | 45 | 0 |
| 2021 | $1.3M | 11,657 | 4,590 |
| 2020 | $691,423 | 6,763 | 2,559 |
| 2019 | $590,066 | 8,832 | 3,670 |
| 2018 | $136,665 | 2,083 | 1,352 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2.0M | 353 | 53.2% |
| Food and Beverage | $1.1M | 28,261 | 30.0% |
| Consulting Fee | $466,067 | 315 | 12.6% |
| Travel and Lodging | $53,012 | 324 | 1.4% |
| Compensation for serving as faculty or as a speaker for a medical education program | $44,573 | 54 | 1.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $20,423 | 27 | 0.6% |
| Space rental or facility fees (teaching hospital only) | $16,173 | 13 | 0.4% |
| Education | $13,754 | 52 | 0.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,240 | 1 | 0.2% |
Payments by Type
Research
$2.0M
353 transactions
General
$1.7M
29,047 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Confirm Rx Insertable Cardiac Monitor SMART Registry | Abbott Laboratories | $670,612 | 0 |
| Arrhythmia Detection After Myocardial Infarction Trial (AID-MI) | Abbott Laboratories | $560,000 | 0 |
| arrhythmia detection after myocardial infarction (AID-MI) Trial | Abbott Laboratories | $300,000 | 0 |
| AIDMI Trial | Abbott Laboratories | $150,000 | 0 |
| ARRHYTHMIA DETECTION AFTER MYOCARDIAL INFARCTION (AID-MI) TRIA | Abbott Laboratories | $126,503 | 0 |
| Confirm Rx Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High Risk Heart Failure Patients | Abbott Laboratories | $100,000 | 0 |
| Human Use Condition Study- Evaluation of Implanted Leads in Humans (HUCS) | Abbott Laboratories | $19,140 | 0 |
| Confirm RX versus Reveal LINQ- which is more reliable in data transmission? | Abbott Laboratories | $18,800 | 0 |
| Confirm Rx Versus Reveal LINQ - Which is More Reliable in Data Transmission? A Randomized Clinical Study | Abbott Laboratories | $10,000 | 0 |
| Confirm Rx versus REVEAL LINQ A Prospective Randomized Clinical Trial Comparing Reveal LINQTM and Confirm RxTM | Abbott Laboratories | $3,200 | 0 |
| COAPT | Abbott Laboratories | $2,600 | 0 |
| AAMI CRMD COMMITTEE LEADS WORKING GROUP STUDY | Abbott Laboratories | $2,507 | 0 |
| Impact of Atrial Fibrillation Burden on Cardiovascular Events | Abbott Laboratories | $1,779 | 0 |
Top Doctors Receiving Payments for Confirm Rx — Page 3
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Clinical Cardiac Electrophysiology | Phoenix, AZ | $3,915 | 140 |
| , MD | Cardiovascular Disease | Miami, FL | $3,857 | 43 |
| George Mark | — | Elmer, NJ | $3,803 | 93 |
| , MD | Clinical Cardiac Electrophysiology | Philadelphia, PA | $3,785 | 25 |
| , DO | Cardiovascular Disease | Chula Vista, CA | $3,754 | 78 |
| , MD | Cardiovascular Disease | Austin, TX | $3,613 | 12 |
| , MD | Cardiovascular Disease | Northridge, CA | $3,544 | 15 |
| , MD | Cardiovascular Disease | Boston, MA | $3,543 | 3 |
| , M.D | Family Medicine | Boca Raton, FL | $3,518 | 45 |
| , M.D | Cardiovascular Disease | Houston, TX | $3,430 | 47 |
| Salman Haq | — | Brooklyn, NY | $3,366 | 4 |
| , M.D | Cardiovascular Disease | Stoneham, MA | $3,330 | 5 |
| , M.D | Cardiovascular Disease | Houston, TX | $3,246 | 72 |
| , M.D | Internal Medicine | Spring, TX | $3,237 | 43 |
| , M.D | Interventional Cardiology | Tarzana, CA | $3,207 | 11 |
| , MD | Cardiovascular Disease | Bryn Mawr, PA | $3,158 | 15 |
| , M.D | Specialist | Odessa, TX | $3,121 | 23 |
| , M.D | Cardiovascular Disease | San Diego, CA | $3,121 | 8 |
| , MD | Cardiovascular Disease | Overland Park, KS | $3,077 | 8 |
| , MD | Internal Medicine | Norwich, CT | $3,022 | 3 |
| , M.D | Cardiovascular Disease | Toledo, OH | $3,014 | 10 |
| , D.O | Cardiovascular Disease | Cherry Hill, NJ | $3,007 | 88 |
| , M.D | Internal Medicine | La Jolla, CA | $2,995 | 23 |
| , M.D | Clinical Cardiac Electrophysiology | Baltimore, MD | $2,976 | 9 |
| , MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Plantation, FL | $2,965 | 32 |
Ad
Manufacturing Companies
- Abbott Laboratories $3.7M
Product Information
- Type Device
- Total Payments $3.7M
- Total Doctors 7,986
- Transactions 29,400
About Confirm Rx
Confirm Rx is a device associated with $3.7M in payments to 7,986 healthcare providers, recorded across 29,400 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2018 to 2024. In 2024, $142,768 was paid across 20 transactions to 0 doctors.
The most common payment nature for Confirm Rx is "Unspecified" ($2.0M, 53.2% of total).
Confirm Rx is associated with 13 research studies, including "Confirm Rx Insertable Cardiac Monitor SMART Registry" ($670,612).